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Abstract: This study was designed to
investigate the role of nitric oxide (NO) in the
differential diagnosis of bacterial, tuberculous
and viral meningitis, and the relation between
cerebrospinal fluid (CSF) NO levels and
meningitis prognosis.
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Twenty patients with bacterial meningitis, 9
with tuberculous meningitis, 11 with viral
meningitis/meningoencephalitis and 21
control patients were included in the study.
CSF NO levels were investigated by measuring
the levels of nitrite with a colorimetric test.
Mean CSF nitrite levels were 3.9 ± 2.0 µmol/l
in bacterial meningitis, 2.7 ± 1.9 µmol/l in
tuberculous meningitis, 1.9 ± 1.7 µmol/l in
viral meningitis/meningoencephalitis and 1.4
± 1.1 µmol/l in control groups. The patients
with bacterial and tuberculous meningitis had
higher CSF nitrite levels than the control

Introduction
Meningitis is an inflammation of the cerebrospinal
membranes that may develop from infectious or noninfectious etiology. Although the etiologies are different,
clinical symptoms and signs are similar in meningitis.
Thus, macroscopic appearance, examination of white
blood cells (WBC), biochemical tests (protein, glucose,
lactate), serological tests, culture and direct
microbiological examination of cerebrospinal fluid (CSF)
are very important in the differential diagnosis of the
meningitis. In spite of these examinations, because of
normal, almost normal or atypical CSF findings,
difficulties in differential diagnosis are often confronted
(1,2).
Meningitis, especially bacterial, has characteristics of
rapid progression and a high mortality rate, as well as
having the potential of forming permanent neurological
or audiological sequelae. Therefore, specific treatment
must be started rapidly. However, despite effective

group (p < 0.05), but the patients with viral
meningitis/meningoencephalitis did not (p >
0.05). However, there was no significant
difference between bacterial and tuberculous
meningitis or between tuberculous meningitis
and viral meningitis/meningoencephalitis
groups. Nitrite levels were correlated with
white blood cell (WBC) counts (r = 0.567, p =
0.000), protein (r = 0.548, p < 0.001) and
glucose levels (r = -0.271, p < 0.05).
In conclusion, although the measurement of
CSF nitrite levels is helpful for the differential
diagnosis of meningitis, this parameter is not
superior to other routine parameters.
However, it may have a characteristic effect
on prognosis.
Key Words: Meningitis, nitric oxide, sequela,
prognosis

treatment, there is no important difference in the
mortality and sequelae of meningitis for the last 30 years
(3). Recently, attention has shifted to the
pathophysiology of meningitis and adjuvant therapy.
Several studies suggest that various inflammatory
mediators including cytokines, platelet activating factor,
arachidonic acid metabolites and reactive oxygen species
contribute to the pathological process of meningitis, and
the development of neuronal injury (4-9). Recent
research suggests that nitric oxide (NO) may have some
important pathophysiological effects during bacterial
meningitis (10-13). However, the role of this molecule is
unclear in other types of meningitis (14,15). NO is
produced from L-arginine by nitric oxide synthase (NOS)
in neutrophils, macrophages, vascular endothelial cells,
astrocytes, microglias and neurons in response to several
immunological stimulations and cytokines. NO is not a
stable substance, and it converts into nitrite and nitrate in
5-10 seconds. It was established that there are roles of
NO in microvascular injury, cerebral edema, CSF

* This study was presented at the XXIXth Turk Microbiology Congress. Antalya, 8-13 October 2000.
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pleocytosis, neurological injury and necrotic cell death in
oligodendroglias (9,10,12,13,16).

two parts: one part was used in routine examinations,
and the other (3 ml) was stored at -20 ºC for study.

In this study, we aimed to investigate the role of NO
in the differential diagnosis and prognosis of meningitis
by determining the CSF levels of nitrate and nitrite, the
stable end products of the NO metabolism.

The measurement of CSF nitrate and nitrite levels

Materials and Methods
Forty patients with meningitis and 21 control subjects
were included in this study between January 1998 and
March 2000. The study was approved by the institutional
ethics committee.
In the presence of clinical evidence of meningitis, the
patients were examined for peripheral blood WBC count,
serum CRP levels, CSF pleocytosis, macroscopic
appearance and biochemical characteristics of CSF. The
patients were divided into three groups as bacterial
meningitis, tuberculous meningitis and viral
meningitis/meningoencephalitis. (i) Bacterial meningitis
was defined as the presence of clinical signs of meningitis,
highly elevated serum C-reactive protein (CRP),
polymorphonuclear pleocytosis in CSF and/or positive
bacterial culture of CSF. (ii) The diagnosis of tuberculous
meningitis was based on the relevant clinical and
laboratory findings, pleocytosis in CSF (which, depending
on the duration of the disease, was dominated by
polymorphonuclear or mononuclear cells), negative
culture for other bacteria and fungi, plus two or more of
the following - showing of acid-fast bacilli on microscopy
or isolation of Mycobacterium tuberculosis from a culture
of CSF, positive tuberculin skin test, evidence of
tuberculosis in another site of the body, and clinical
response to anti-tuberculous treatment. (iii) The
diagnosis of viral meningitis/meningoencephalitis was
based on clinical manifestations, negative or slightly
elevated serum CRP, mononuclear pleocytosis in CSF, and
negative bacterial and fungal cultures. The control group
consisted of subjects who presented meningeal irritation
signs that required analysis of CSF to exclude the
presence of meningitis or diseases of central nervous
system. They were later found to be free of such diseases
based on the results of CSF examinations and negative
clinical findings during follow up. Patients treated with
antibiotics or anti-inflammatory agents before lumbar
puncture were excluded from the study. CSF samples,
obtained on the first day of admission, were divided into
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The concentrations of nitrite and nitrate, the stable
end products of NO in CSF, were measured using a
colorimetric test (17). In the first step, nitrite levels in
CSF were determined by Griess reactive, which converts
nitrite into a deep purple azo compound (Nitrite/nitrate
Colorimetric Assay Kit Boehringer, Mannheim, Germany).
The absorbance of standards and samples were measured
by spectrophotometer at 550 nm. Later, the combined
levels of nitrite and nitrate were determined by the same
method after the enzymatic reduction of nitrate to nitrite
using nitrate reductase (1 U/ml). The CSF nitrate
concentration was calculated by subtracting the nitrite
level from the combined level. The detection limits of
nitrite and nitrate were 0.3 and 0.2 µmol/l respectively.
Statistical analysis
Statistical analysis was made by variant analysis in
SPSS version 10.0. LSD multiple comparison test was
used for the determination of differences between the
groups.
Correlations between parameters were evaluated in
all study subjects and controls, and were calculated by
Pearson’s method. A p value < 0.05 denoted the presence
of statistical significance.
Results
Forty patients (23 males, 17 females) were included
in this study. The mean ± SD age of the patients was
34.7±18 (median: 31.0, range: 14-78 years). Twenty
patients had bacterial meningitis, nine tuberculous
meningitis and 11 viral meningitis/meningoencephalitis.
Twenty-one subjects with a mean age of 36 ± 18
(median: 30, range: 14-73, 12 males and 9 females)
were included as a control group.
In the bacterial meningitis group, Streptococcus
pneumoniae was isolated in four, Neisseria meningitidis in
two, and Bacillus anthracis in one of the patients. No
causative agent was detected in the other 13 cases. In the
tuberculous
meningitis
group,
Mycobacterium
tuberculosis was detected by culture and/or direct
examination of CSF in four cases. In the viral
meningitis/meningoencephalitis group, although virus
isolation was not conducted, it was assumed that viruses
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were the causative agents. According to clinical features,
two patients were diagnosed as having Herpes simplex
encephalitis and two mumps meningitis.
Six patients (3 bacterial, 2 tuberculous, 1 viral
meningitis/meningoencephalitis) died, and three patients
developed neurological or audiological sequelae (2
bacterial and 1 tuberculous meningitis).
The CSF nitrite, nitrate, protein, glucose and WBC
values of the patients and control subjects are shown in
Table 1.
Nitrite levels in the CSF samples of the patients with
bacterial and tuberculous meningitis were significantly
elevated in comparison with the control group (p < 0.01,
p < 0.05, respectively). However, no significant
elevations were found in patients from the viral
meningitis/meningoencephalitis group (p > 0.05). The
highest mean value of nitrite (3.9±2.0 µmol/l) was
detected in the bacterial meningitis group. It was
observed that CSF nitrite levels had a more homogeneous
distribution than nitrate levels (Table 1).
When comparing nitrite levels, a significant difference
was found between the bacterial and viral
Table 1.

meningitis/meningoencephalitis groups (p < 0.01), but
there was no difference between bacterial - tuberculous
meningitis groups (p > 0.05), and the viral
meningitis/meningoencephalitis - tuberculous meningitis
groups (p > 0.05).
No significant difference was found between the CSF
nitrite levels of the patients who died or those who
recovered (p > 0.05). In bacterial meningitis group,
however, the CSF nitrite levels of three patients who died
(4.5, 5.3, 9.1 µmol/l) and one patient who had sequela
(4.4 µmol/l) were higher than the mean value (3.9
µmol/l) of this group, but the others were not. The CSF
nitrite level of the patient who had sequela in the
tuberculous meningitis group (5.5 µmol/l) was also
higher than the mean levels of this group (2.7 µmol/l),
(Table 2).
Although mean protein and glucose levels of the
bacterial and tuberculous meningitis groups were
significantly
different
from
the
viral
meningitis/meningoencephalitis and control groups (p <
0.05 when comparing the glucose levels of the bacterial
meningitis and control group, and p < 0.01 for the

Clinical and laboratory characteristics of the patients and control subjects.

Age, years
(range)
Sex
Male
Female
CSF (range)
WBCd/mm3
PNLe/mm3
MNLf/mm3
Glucose,mg/dl
Protein,mg/dl
Nitrate, µmol/l
Nitrite, µmol/l

BMa(mean ± SD)
n = 20

TMb (mean ± SD)
n=9

VMc(mean ± SD)
n = 11

Control (mean ± SD)
n = 21

34 ± 18
(15 - 78)

40 ± 19
(16 - 65)

30 ± 10
(14 - 73)

36 ± 18
(14 - 73)

14
6

2
7

7
4

13
8

3606.5 ± 2135.6
(1390 - 8500)
2807.5 ± 1737.0
(700 - 7250)
799 ± 717.3
(220 - 3000)
42.8 ± 15.3
(6 - 75)
244.95 ± 141.3
(60 - 570)
7.7 ± 4
(1.3 - 14.3)
3.9 ± 2.0*
(1.4 - 9.1)

287.8 ± 168.6
(50 - 510)
91.1 ± 73.4
(20 - 270)
196.7 ± 138.1
(20 - 400)
27.3 ± 19.2
(10 - 67)
190.78 ± 94.4
(99 - 358)
14.7 ± 18.6
(1.9 - 62.6)
2.7 ± 1.9*
(0.8 - 6.2)

108.2 ± 149.6
(10 - 500)
15.5 ± 38.6
(0 - 130)
92.7 ± 114.6
(10 - 370)
68.2 ± 40.8
(5 - 151)
45.27 ± 20.0
(21 - 87)
6.6 ± 4.7
(0.6 - 17.0)
1.9 ± 1.1
(0.6 - 3.4)

10 ± 8.4
(0 - 12)
0
(0 - 0)
10 ± 8.4
(0 - 20)
56.7 ± 9.7
(38 - 76)
31.57 ± 9.4
(15 - 45)
5.5 ± 3.9
(0.2 - 12.9)
1.37 ± 0.8
(0.3 - 2.9)

a

BM:Bacterial meningitis, bTM:Tuberculous meningitis, cVM:Viral meningitis/meningoencephalitis, dWBC: White blood cell, ePNL: Polymorphonuclear
leukocyte, fMNL: Mononuclear leukocyte, * p < 0.05 compared with control group
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Table 2.

CSF nitrite levels (µmol/l) of the patients who died and
those who had sequelae.
Patients
who died
n=6

BM

Patients with
sequelae
n=3

Mean ± SD
of the groups

4.5

4.4

3.9 ± 2.0

5.3

1.7

9.1
TM

2.4

5.5

2.7 ± 1.7

-

1.9 ± 1.1

2.6
VM

0.9

BM: Bacterial meningitis, TM: Tuberculous meningitis,
VM: Viral meningitis/meningoencephalitis

others), no difference was found between the bacterial tuberculous meningitis groups and the viral
meningitis/meningoencephalitis - control groups
(p>0.05).
We investigated the correlations between nitrite levels
and WBC counts, and protein and glucose levels of CSF. A
positive correlation was found between nitrite levels and
WBC counts (r = 0.567, p < 0.001), and nitrite levels and
protein levels (r = 0.548, p < 0.001). A negative
correlation was found between nitrite and glucose levels
(r = -0.271, p < 0.05). No correlation was found
between nitrite and nitrate levels, or age and sex.
Discussion
The first step of the inflammatory process in
meningitis, which is triggered by entry of the pathogen
into subarachnoid space, is the releasing of cytokines,
interferons, arachidonic acid metabolites, plateletactivating factor and complement components by
stimulation of lipopolysaccharide, lipoteichoic acid,
peptidoglican, bacterial toxins or viral components
(7,8,18). By induction of these inflammatory mediators,
a variety of effector final mediators including reactive
oxygen species (superoxide, peroxynitrite, etc.), reactive
nitrogen species (NO) and excitatory amino acids
(glutamate, aspartate, taurine, alanine) are produced
(4,19). These mediators are responsible for changes in
the central nervous system during meningitis. However,
the mechanisms responsible for damage in the central
nervous system are not yet completely understood. In
recent experimental studies, it was observed that NO
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destroyed the blood-brain barrier either directly or
mediately by the effect of TNF-α (9,20,21). By
administration of NO synthase (NOS) inhibitors, an
increase in regional blood flow and destruction of the
blood-brain barrier was prevented. Furthermore,
decreasing brain edema, intracranial pressure and CSF
leukocyte count were observed (13,22).
However, Leib et al. (23) demonstrated that
production of NO was reduced by the administration of
aminoguanidin, a NOS inhibitor, in early and late stages of
experimental meningitis, but CSF bacteria count and
convulsion incidence increased. Based on these results,
they claimed that NO was useful in reducing cerebral
ischemia. In addition to experimental studies, several
clinical studies showed increased CSF-NO levels in
bacterial meningitis (11,12,15,24). Similar results were
reported in studies concerning tuberculous meningitis
(25,26).
Although the role of NO is more evident in bacterial
meningitis, its role in viral meningitis is not clear.
Shigemoto et al. (14) reported that there was inducible
nitric oxide synthase (iNOS) induction and an elevation of
NO levels in the brain tissue of rats, and clinical healing
was observed after the administration of iNOS inhibitors
in the experimental model of encephalitis with Herpes
simplex type-1. Milstien et al. (27) observed an elevation
of CSF nitrite/nitrate levels in a small group of patients
with viral meningitis. However, an increase in CSF-NO
levels was not observed in the other clinical studies
concerning viral meningitis (15,24,26). In this study, we
did not observe an elevation in the CSF nitrite levels of
the patients with viral meningitis/meningoencephalitis
compared with the control subjects.
According to the results of several studies, Gramnegative bacteria induce TNF-α stronger than Grampositive bacteria, and cause higher CSF-NO levels
(10,15,28). Since we detected Gram-positive bacteria
only in two cases, we could not perform such an
evaluation. The highest nitrite level (9.1 µmol/l) in our
study was measured in the CSF of the patient with
anthrax meningitis who died 6 hours after
hospitalization. The cause of the highest level might be
due to the severe clinical progress of the patient or the
hemorrhagic characteristic of the CSF.
Nitrate is the major metabolic end product of NO in
the circulation, and it was suggested that elevated nitrate
levels of CSF during bacterial meningitis were the result
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of either diffusion from the disrupted blood-brain barrier
or enhanced production of NO in bacterial meningitis
(10). However, CSF is comparable to an oxygen
containing aqueous solution, a condition in which NO is
oxidized primarily to nitrite with little or no formation of
nitrate, and the CSF concentration of nitrite per se may
provide a more specific parameter for gauging
endogenous NO production in the central nervous system
(15). In addition, according to previous studies
(10,12,15,24,26,29), CSF nitrate levels during bacterial
meningitis are more heterogeneous than nitrite levels, as
shown in this study. Therefore, it was considered that the
CSF nitrite level is an indicator of endogenous NO
production in CSF. For these reasons, we took nitrite
levels into consideration as an indicate of NO production
in central nervous system.
Murawska et al. (24) reported the correlations
between CSF nitrite-leukocytes, and nitrite-protein levels
in bacterial meningitis, as we observed in this study. If it
is kept in mind that NO contributes to meningeal
inflammation, destroys the blood-brain barrier and
facilitates protein transporting to CSF, it is logical to
assume the presence of a correlation between CSF nitrite
and protein. In studies that did not detect a correlation
between CSF nitrite level and leukocyte count, it was
emphasized that a "major source of nitrite was not
inflammatory cells" (10,30). We think this opinion is
correct. Although we found a significant correlation
between these two parameters, the correlation was not
strong. We also found a negative correlation between CSF
nitrite and glucose levels. Similar results have been
reported in other studies (10,29). The low glucose levels
may be explained by the inhibition of mitochondrial
respiration that enhances anaerobic glycolysis through
excessive NO production (31,32). In addition, inhibition
of the carrier-mediated transport system across the
blood-brain barrier causes decreased CSF glucose levels in
bacterial meningitis.

Recent studies have suggested that NO may be
responsible for neurological and audiological sequelae in
bacterial meningitis (10,33). In our study, two patients
with bacterial meningitis and one patient with
tuberculous meningitis developed neurological or
audiological sequelae. Two of the three patients (one
bacterial and one tuberculous meningitis) had higher
levels of nitrite than the median levels of their own
groups. No significant difference was found between the
CSF nitrite levels of the patients who died and those who
recovered (p > 0.05). However, the CSF nitrite levels of
three patients who died in the bacterial meningitis group
were higher (4.5, 5.3, and 9.1 µmol/l) than the mean
value of this group. The absence of significant differences
between the patients who died and those who recovered
may be due to the limited number of patients. Further
studies are required to evaluate the relationship between
NO and prognosis.
According to our data, CSF glucose and protein levels
were not helpful for the differentiation of bacterial and
tuberculous meningitis. However, our case numbers were
limited, and our results suggest that CSF nitrite
measurements were also not helpful for the differential
diagnosis of bacterial and tuberculous, or tuberculous and
viral meningitis.
In conclusion, although CSF nitrite measurement is no
more useful than other routine examinations in the
differential diagnosis of meningitis, enhanced NO
production may have an important effect on prognosis
and may contribute to the pathophysiology of bacterial
and tuberculous meningitis.
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